Alaunos Therapeutics, Inc.
0.00%
0
1107421
98973P309
Aug 21, 2025
Sep 5, 2025, 05:20 PM
Reporting Persons (2)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| PMGC CAPITAL LLC | CO | 0.00% | 0 | 0 | 0 |
| PMGC Holdings Inc. | Other | 0.00% | 0 | 0 | 0 |
Disclosure Items (5)
Common Stock
Alaunos Therapeutics, Inc.
501 E LAS OLAS BLVD, FORT LAUDERDALE, FL, 33301
This Amendment No. 1 to Schedule 13D is filed on behalf of PMGC Capital LLC ("PMGC LLC"). PMGC Holdings Inc. ("PMGC Holdings") is currently the sole member of PMGC LLC. Currently, PMGC Holdings no longer exercises any voting and dispositive control over the Common Stock previously beneficially owned by PMGC LLC.
The principal business address of PMGC LLC is 120 Newport Center Drive, Ste. 249, Newport Beach, California 92660.
PMGC LLC is a multi-strategy investment firm focused on direct investments, strategic lending, and acquiring undervalued companies and assets across diverse markets. PMGC LLC is a wholly-owned subsidiary of PMGC Holdings.
During the last five years, neither PMGC LLC nor PMGC Holdings has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction which resulted in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
PMGC LLC is organized under the laws of Nevada.
Item 3 is hereby replaced in its entirety as follows: Not applicable. This Amendment No. 1 reports the Transactions (as defined below).
Item 5(a) of the Original Schedule 13D is hereby replaced in its entirety as follows: As of August 25, 2025, the Reporting Persons are no longer beneficial owners or no longer may be deemed to be beneficial owners (as the case may be), of any shares of Common Stock.
Item 5(b) of the Original Schedule 13D is hereby replaced in its entirety as follows: As of August 25, 2025, the Reporting Persons are no longer beneficial owners or no longer may be deemed to be beneficial owners (as the case may be), of any shares of Common Stock.
Item 5(c) of the Original Schedule 13D is hereby replaced in its entirety as follows: Between June 16, 2025 and August 22, 2025, PMGC LLC sold all of the Common Stock of the Issuer on the open market at prices ranging between $1.92 to $4.53.
Not applicable.
Not applicable.